By: ChinaBio® Today
December 29, 2012 at 05:34 AM EST
Week in Review: Unnamed China Pharma Buys Bayer’s Vacated Bay-Area Campus
A major, though still unnamed, China biopharma bought a prestigious San Francisco-area biotech campus (it formerly belonged to Bayer) and will disclose its plans for the site next month; HitGen and Viva Biotech, two China CROs specializing in early-stage services, will partner up to provide an early-stage hit-to-lead-generation program; Naton Medical, a Beijing maker of orthopedic products, joined with two Malaysia-based medical device companies, OSA Niaga and Straits Orthopedics, to form a Malaysian JV; and India will locate its own drug inspection office in China in March of 2013, complete with four full-time inspectors. More details…. Stock Symbol: (Xetra: BAY) Share this with colleagues: // //
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here